SCHEMBL25996710

SCHEMBL25996710

c1ccc(-c2cc3c4ccccc4sc3c3[nH]c4ccccc4c23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ MAPT P10636 3/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ TNKS O95271 2/20 0.51
▸ TNKS2 Q9H2K2 2/20 0.51
▸ MAP3K9 P80192 4/20 0.50
▸ MAP3K11 Q16584 4/20 0.50
▸ CDK4 P11802 1/20 0.50
▸ CCND1 P24385 1/20 0.50
▸ NTRK1 P04629 1/20 0.45
▸ MAP3K10 Q02779 1/20 0.45
▸ HTT P42858 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ NCOA2 Q15596 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18688084 0.87 MEN1 (0.51) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL24722904 0.86 TNKS (0.48) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL25681761 0.83 MEN1 (0.56) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL17524724 0.82 MEN1 (0.46) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL21282039 0.80 MEN1 (0.59) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL20175697 0.80 MEN1 (0.59) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL15638451 0.77 KMT2A (0.49) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL15138782 0.77 MEN1 (0.69) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL30887363 0.77 MEN1 (0.69) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL29506382 0.77 MEN1 (0.69) MEN1KMT2AMAPTRAB9ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 MEN1 2227/4885KMT2A 930/4885MAPT 1225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback